Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by besttobeon Nov 03, 2023 9:14am
91 Views
Post# 35715424

RE:HME Article-Reimbursement relief, 20% inc/decr. on the line

RE:HME Article-Reimbursement relief, 20% inc/decr. on the lineRecent HME article update below....Bid relief could help VMD a bit but not as much as other HME with different product lines....Still a bit of a help no less.....

BID RELIEF LANGUAGES TAKES ‘SIGNIFICANT STEP FORWARD’PROVIDERS URGED TO CALL THEIR SENATORS

WASHINGTON – Language that would extend the 75/25 blended Medicare reimbursement rate in non-bid areas through 2024 is included a draft of omnibus health care legislation in advance of a Senate Finance Committee mark-up session that could take place as early as next week. 

Inclusion in this initial draft of legislative language to be considered by the committee does not guarantee the 75/25 provisions from S. 1294 will,ultimately, pass into law, but it's a significant step forward in the legislative process, says AAHomecare in a bulletin. 

HME advocates in states with Senate Finance Committee members are urged to send an email to health care committee staffers this week with this message(in your own words, if possible): 

“Please support language from S. 1294 to extend the 75/25 blended Medicare reimbursement rate for DME through 2024 in upcoming Senate Finance Committee consideration of healthcare legislation (section 405 of related legislative discussion draft). This measure will help DME suppliers continue to provide cost-effective, patient-preferred home-based care and send a message to CMS that a longer-term, market-based solution is needed.” 

These states are represented by a senator on the Finance Committee: Colorado, Delaware, Idaho, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Montana, New Hampshire, Nevada, New Jersey, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, Wyoming. 

AAHomecare recommends calling the senator’s office and asking for the name and email of the individual who handles health care issues; most offices will readily share that information. 



<< Previous
Bullboard Posts
Next >>